William Petri headshot
WP

Bill Petri

Professor
Unit: School of Medicine
Department: Department of Medicine, Infectious Diseases
Office location and address
345 Crispell Dr
Charlottesville, Virginia 22903
Education
Clinical Fellowship, Infectious Diseases, University of Virginia
Residency, Internal Medicine, University Hospital of Cleveland
PhD, Microbiology & Infectious Diseases, University of Virginia
MD, University of Virginia
Biography

Dr. Petri is the chief of the Division of Infectious Diseases and International Health at UVA, and head of the Infectious Diseases Training Program for graduate students and postdoctoral fellows. He attends in general internal medicine and in the subspecialty of infectious diseases. He has a special interest in international health and in the study of C. difficile, and his substantial research program is supported by the National Institutes of Health and the Bill & Melinda Gates Foundation.  

Dr. Petri was born and raised primarily in Washington, D.C., but spent his third grade year in London with his family, a formative experience that he credits as being partly responsible for the international focus of his research. He attended the University of Wisconsin – Madison, moving to Charlottesville in 1976 to start medical and graduate school at UVA. After obtaining his MD and PhD in microbiology, he married his medical school classmate Mary Ann McDonald and they moved to Cleveland for residency training at Case Western Reserve University. There, Dr. Petri completed an internship and residency in internal medicine, followed by a return to Charlottesville in 1985 for an infectious diseases fellowship. He has been here ever since. 

He and Mary Ann have five grown children, and as they have left the nest his interests have shifted from coaching their soccer teams (36 seasons) to a return to music (trombone) and a new interest in running, including training for the Chicago Marathon.

The Impact and Regulation of IL-6 in Clostridioides difficile Infection Fellowship on behalf of Tyus
Source: U.S. NIH Institute of Allergy & Infectious Disease
August 01, 2021 – July 31, 2025
Role of Th17 in Severe and Recurrent C. difficile Infection
Source: U.S. NIH Institute of Allergy & Infectious Disease
July 01, 2020 – June 30, 2025
Polymorphisms link Protein Kinase C- ¿ to Cryptosporidia susceptibility in 1st year of life
Source: U.S. NIH Institute of Diabetes & Digestive & Kidne
July 01, 2020 – June 30, 2025
Biodefense & Infectious Diseases Short-Term Training to Increase Diversity in Biomedical Research - YRS16-20
Source: U.S. National Institutes of Health (NIH)
June 01, 2019 – May 31, 2025
MD-INMD-ID The Bangladesh Environmental enteric Dysfunction (BEED) Study
Source: International Centre for Diarrhoeal Disease Resear
February 01, 2016 – April 30, 2025
Field Studies of Cryptosporidiosis in Bangladesh
Source: U.S. NIH Institute of Allergy & Infectious Disease
March 20, 2019 – February 29, 2024
A-PLUS Trial: Multi-site Efficacy and Safety Trial of Intrapartum Azithromycin in LMICs
Source: Foundation for the National Institutes of Health
October 01, 2019 – July 31, 2023
MD-INMD-ID-T32-Global Biothreats Training Program
Source: U.S. NIH Institute of Allergy & Infectious Disease
August 08, 2018 – June 30, 2023
Role of CREM in Amebic Colitis and Inflammatory Bowel Disease
Source: U.S. NIH Institute of Allergy & Infectious Disease
January 10, 2018 – December 31, 2022
Dupixent (Dupilumab) Clinical Investigation
Source: Virginia Biosciences Health Research Corporation
April 01, 2021 – December 31, 2022
Subunit Vaccine for Cryptosporidiosis
Source: U.S. NIH Institute of Allergy & Infectious Disease
December 07, 2020 – November 30, 2022
Advanced development of a synthetic intranasal vaccine for Entamoeba histolytica_Option2
Source: Infectious Disease Research Institute
March 15, 2021 – September 17, 2022
MD-INMD ID308 Infectious Diseases Training Program
Source: U.S. NIH Institute of Allergy & Infectious Disease
July 01, 2017 – July 31, 2022
The role of the Western diet in increasing severity of Clostridium difficile infection
Source: U.S. NIH Institute of Diabetes & Digestive & Kidne
July 01, 2020 – June 30, 2022
MD-INMD Role of eosinophils in innate protection from C. difficile
Source: U.S. NIH Institute of Allergy & Infectious Disease
February 02, 2016 – January 31, 2022
Development of a test battery to evaluate brain and cognitive function in the first 2 years of life suitable for deployment in low income countries
Source: Children's Hospital Corporation, The
January 01, 2019 – August 31, 2021
Advanced development of a synthetic intranasal vaccine for Entamoeba histolytica - Option 1
Source: Infectious Disease Research Institute
November 01, 2020 – August 31, 2021
Advanced development of a synthetic intranasal vaccine for Entamoeba histolytica
Source: Infectious Disease Research Institute
October 15, 2018 – August 31, 2021
Scanning the Cryptosporidium proteome for vaccine antigens
Source: IMMPORT THERAPEUTICS, INC.
April 01, 2020 – March 31, 2021
C. difficile IFA test evaluation and Reproducibility study
Source: TechLab, Inc.
August 22, 2019 – August 21, 2020
Identification of pan- Cryptosporidium drug targets using a combined computational & experimental approach
Source: PhRMA Foundation
January 01, 2019 – July 31, 2020
Quantitative Decision Making Tools in Criminal Justice
Source: Macarthur Foundation
January 01, 2018 – June 30, 2020
MD-INMD-ID-WAP3G-Gilmartin F30; The Role of Lysosomes and Amoebapores in Amoebic Trogocytosis and Cell Killing
Source: U.S. NIH Institute of Allergy & Infectious Disease
June 01, 2016 – May 31, 2020
Pilot Study of DiaResQ for the Treatment of Environmental Enteric Dysfunction
Source: PanTheryx, Inc.
April 25, 2017 – April 09, 2020
MD-INMD Microbiome and Metabolomic Analysis of Selected PROVIDE Samples
Source: Bill & Melinda Gates Foundation
October 25, 2017 – January 30, 2020
Balancing TLR2 and IL-33 immune pathways to protect during epidemic Clostridium difficile infection
Source: U.S. NIH Institute of Allergy & Infectious Disease
July 01, 2018 – May 31, 2019
MD-DMED Biodefense & Infectious Disease Short Term Training for Minority Students
Source: U.S. NIH Institute of Allergy & Infectious Disease
June 09, 2014 – May 31, 2019
MD-INMD Field Studies of Cryptosporidiosis in Bangladesh Yr18
Source: U.S. NIH Institute of Allergy & Infectious Disease
September 20, 2013 – March 20, 2019
MD-INMD Development of a test battery to evaluate brain and cognitive function in the first 2 years of life suitable for deployment in low income countries YR03
Source: Children's Hospital Corporation, The
September 01, 2016 – December 31, 2018
MD-INMD-ID Improving Rotavirus Vaccination: Refining Correlates of Protection and Evaluating Durability
Source: University of Vermont
October 01, 2015 – September 30, 2018
Immunoprofiling of IgA and IgG Specific to Enteric and Respiratory Pathogens in Human Milk
Source: University Of Rochester
October 01, 2017 – September 30, 2018
Clinical Evaluation of the TECHLAB H. PYLORI QUIK CHEK and H. PYLORI CHEK
Source: TechLab, Inc.
June 26, 2017 – August 31, 2018
Clinical Evaluation of the TECHLAB H. PYLORI QUIK CHEK and H. PYLORI CHEK
Source: TechLab, Inc.
June 26, 2017 – August 31, 2018
MD-INMD-ID Assessment of Community Transmission of Sabin Type 2 Virus in Bangladesh
Source: Bill & Melinda Gates Foundation
January 20, 2015 – June 30, 2018
MD-INMD Biodefense Research Training and Career Development
Source: U.S. NIH Institute of Allergy & Infectious Disease
July 01, 2013 – June 30, 2018
Exploration of the Biologic Basis for Underperformance of OPV and Rotavirus Vaccines in Bangladesh and India
Source: Bill & Melinda Gates Foundation
November 16, 2010 – May 31, 2018
Phase IIa Clinical Trial of the Reprofilled Druge Auranofin for GI Protozoa - YR03
Source: The Regents of the University of California
May 05, 2017 – April 30, 2018
MD-INMD-ID Role of IL-23 in the Immunopathogenesis of C Difficile Colitis
Source: U.S. NIH Institute of Allergy & Infectious Disease
May 01, 2015 – April 30, 2018
MD-INMD-ID 308-Infectious Diseases Training Program Year 40
Source: U.S. NIH Institute of Allergy & Infectious Disease
July 01, 2012 – March 08, 2018
MD-INMD Role of Leptin in Innate Mucosal Defense from Amebiasis
Source: U.S. NIH Institute of Allergy & Infectious Disease
May 15, 2012 – January 09, 2018
MD-INMD Morbidity Burden from Cryptosporidiosis at GEMS-Bangladesh
Source: International Centre for Diarrhoeal Disease Resear
March 25, 2014 – September 30, 2017
MD-INMD Development of a test battery to evaluate brain and cognitive function in the first 2 years of life suitable for deployment in low income countries
Source: Children's Hospital Corporation, The
September 05, 2015 – August 31, 2017
MD-INMD-ID Nanoformulation of Syngergistic TLR Ligands to Enhance Amebiasis Vaccine Efficacy-Yr2
Source: Infectious Disease Research Institute
August 01, 2015 – July 31, 2017
New therapeutics for ameobiasis in children
Source: The Hartwell Foundation
January 01, 2013 – June 30, 2017
MD-INMD Transmission of Cryptosporidiosis in Rural and Urban Bangladesh
Source: Johns Hopkins University, The
May 28, 2015 – June 19, 2017
MD-INMD-ID Investigation into diagnostics for eosinophils biomarkers for eosinophilia
Source: TechLab, Inc.
June 13, 2016 – June 13, 2017
MD-INMD Phase lla Clinical Trial of the Reprofiled Drug Auranofin for GI Protozoa-YR2
Source: University of California, San Diego
May 01, 2016 – April 30, 2017
MD-INMD Biodefense Research Training and Career Developement
Source: U.S. NIH Institute of Allergy & Infectious Disease
July 01, 2013 – January 31, 2017
MD-INMD-ID308-Infectious Diseases Training Program Year 36
Source: U.S. NIH Institute of Allergy & Infectious Disease
July 01, 2012 – September 30, 2016
MD-INMD-ID Metabolomic services for Chalmers Institute
Source: Chalmers University of Technnology
December 01, 2015 – August 31, 2016
MD-INMD Field Studies of Cryptosporidiosis in Bangladesh
Source: U.S. NIH Institute of Allergy & Infectious Disease
September 20, 2013 – August 31, 2016
Role of Leptin in Innate Mucosal Defense from Amebiasis
Source: U.S. NIH Institute of Allergy & Infectious Disease
May 15, 2012 – April 30, 2016
MD-INMD-ID The Role of IL-23 in the Pathogenesis of Clostridium Difficile Infection
Source: U.S. NIH Institute of Allergy & Infectious Disease
September 01, 2014 – April 22, 2016
Uptake Transport & Delivery Of Trovafloxacin Human
Source: Merck Sharp & Dohme Corp.
January 01, 1980 – April 07, 2016
Quik Chek Rapid Immunity Assessment Test
Source: Bill & Melinda Gates Foundation
November 08, 2012 – March 31, 2016
Study of Risk Factors for Malnutrition Using Molecular & Genomic Tools
Source: Bill & Melinda Gates Foundation
November 01, 2008 – December 31, 2015
MD-INMD THe Role of Leptin in Susceptibility to Amebiasis - Fellowship on behalf of Chelsea S. Marie
Source: U.S. NIH Institute of Allergy & Infectious Disease
July 01, 2012 – October 31, 2015
MD-INMD-ID Production of a Reg1B Fecal Enzyme Immunoassay as a Potential Biomarker of Childhood Stunting
Source: Bill & Melinda Gates Foundation
October 24, 2013 – September 30, 2015
MD-INMD-ID Development of a test battery to evaluate brain and cognitive function in the first 2 years of life suitable for deployment in low income countries
Source: Children's Hospital Corporation, The
September 05, 2014 – September 04, 2015
MD-INMD Nanoformulation of Synergistic TLR Ligands to Enhance Amebiasis Vaccine Efficacy
Source: Infectious Disease Research Institute
August 15, 2014 – July 31, 2015
Characterize Respiratory Pathogens Endemic to Pakistan
Source: U.S. DOD - Defense Threat Reduction Agency
July 01, 2012 – June 30, 2015
MD-INMD-WAP3G Sub to University of Washington Molecular Pipeline
Source: University of Washington
April 01, 2013 – March 31, 2015
MD-INMD Passive and Acquired Immunity to Cryptosporidiosis in Bangladeshi Children (fellow Poonum Korpe)
Source: U.S. NIH Institute of Allergy & Infectious Disease
June 19, 2014 – August 31, 2014
MD-INMD-ID Role of Leptin in Mucosal Protection During Clostridium Difficile Infection (Fellow Rajat Madan)
Source: U.S. NIH Institute of Allergy & Infectious Disease
August 01, 2014 – August 01, 2014
MD-DMED Biodefense & Infectious Disease Short-Term Training for Minority Students
Source: U.S. NIH Institute of Allergy & Infectious Disease
June 10, 2009 – June 08, 2014
Point-of-Care Test for Entamoeba Histolytica Cysts
Source: TechLab, Inc.
June 04, 2012 – May 31, 2014
MD-INMD-ID308-PointofCare Test YR2
Source: TechLab, Inc.
June 01, 2013 – May 31, 2014
MD-INMD MARCE-2 Mid-Atlantic Regional Center of Excellence in Biodefense YR5
Source: University Of Maryland
March 01, 2013 – February 28, 2014
MD-INMD Biodefense Research Training and Career Development
Source: U.S. NIH Institute of Allergy & Infectious Disease
July 01, 2008 – October 31, 2013
Field Studies of Human Immunity to Amebiasis in Bangladesh
Source: U.S. NIH Institute of Allergy & Infectious Disease
January 01, 2008 – September 19, 2013
Alum-absorbed subunit vaccine to prevent intestinal amebiasis
Source: TechLab, Inc.
July 16, 2011 – June 30, 2013
Alum-absorbed Subunit Vaccine to Prevent Intestinal Amebiasis - Year 2
Source: TechLab, Inc.
July 01, 2012 – June 30, 2013
Flow Cytometry for BSL 3
Source: U.S. National Center For Research Resources
September 15, 2010 – June 14, 2013
Multi-Center Severe Diarrheal Disease Burden & Etiology Study
Source: University Of Maryland
May 01, 2006 – May 31, 2013
MD-INMD The Life Sciences Research Foundation Postdoctoral Research Fellowship
Source: The Life Sciences Research Foundation
June 01, 2010 – May 31, 2013
Accelerated Molecular Probe Pipeline UW
Source: University of Washington
October 01, 2012 – March 31, 2013
MARCE2 Mid-Atlantic Regional Center of Excellence in Biodefense YR4
Source: University Of Maryland
March 01, 2012 – February 28, 2013
MD-INMD Infectious Diseases Training Program
Source: U.S. NIH Institute of Allergy & Infectious Disease
July 01, 2008 – January 31, 2013
INST 2550: Interdisciplinary Studies Hereford College
Credits: 1–3
Individual faculty and advanced graduate students may teach these courses with the approval of the Dean's Office, which acts for the Committee on Education Policy and the Curriculum. A maximum of 3.0 credits count toward the B.A. or B.S. in the College. INST courses count as non-College credits.
BIMS 8995: Topical Research: Research in Biomedical Sciences
Credits: 1–12
This course introduces students to biomedical research. Students conduct one or more research projects of limited scope under the direction of faculty and lab members. It is open only to graduate students in Biomedical Sciences (BIMS).
MICR 9995: Research in Microbiology, Immunology and Infectious Diseases
Credits: 1–12
Research in microbiological related disciplines, e.g. cancer, immunology, bacteriology, virology, infectious diseases, cell signaling, nuclear transport, host-pathogen interactions, gene expression, etc.
PATH 9995: Topical Research
Credits: 1–12
Original research on approved problems.
BIOC 9995: Topical Research: Biochemistry and Molecular Genetics
Credits: 3–12
Topical Research
BIOC 9998: Non-Topical Research: Preparation for Doctoral Research
Credits: 1–12
Non-Topical Research: Preparation for Doctoral Research
NESC 9999: Non-Topical Research
Credits: 1–12
For doctoral research, under the supervision of a dissertation director.
PATH 9999: Non-Topical Research
Credits: 1–12
Dissertation research credit for students who have completed their advancement to candidacy.
MICR 9999: Non-Topical Research
Credits: 1–12
For doctoral dissertation, taken under the supervision of a dissertation director.
BIOC 9999: Non-Topical Research
Credits: 1–12
For doctoral dissertation, taken under the supervision of a dissertation director.

2015-2018 Best Doctors in America® Lis